PHF6 and leukemia: Comprehensive profiling of TSPAN32 expression across genetically annotated patient cohorts will be necessary to delineate the precise relationship between leukemia subtype, underlying mutations (e.g., NOTCH1, FBXW7, PHF6, HOXA cluster abnormalities), and TSPAN32 regulation.